James Butkiewicz, a professor of economics at the University of Delaware, “There are two outcomes: either there will be fewer AstraZeneca’ jobs in Delaware, or there will be none.”
Faculty & Research
Lerner in the Media
“A decade ago, directors were seen but not heard,” says Charles Elson at UD. “The world has changed. Investors are withholding against director candidates."
Charles Elson, a corporate governance expert at the University of Delaware, said resounding shareholder defeats of company-backed plans are unusual.
The Blue Hen Investment Club, which manages $1.5 million of UD’s endowment, is highlighted in the article.
James Butkiewicz, economics, discussed the direct effects of Pfizer's potential acquisition of Astra Zeneca.
Charles Elson, director, Weinberg Center for Corporate Governance, discussed stock awards as CEO compensation.
Op-ed piece cites a study conducted at UD during the annual Economic Forecast sponsored by Lyons Companies and the Center for Education and Entrepreneurship that shows expectations of an improving economy.
Charles Elson, Weinberg Center for Corporate Governance, commented on a court case surrounding a utility surcharge.
Dan Freeman, director of the Horn Program in Entrepreneurship, was cited for leading efforts to launch the Venture Development Center at UD.
Charles Elson, director of John L. Weinberg Center of Corporate Governance, is quoted.